Care Capital
Care Capital, a life science–focused venture capital firm, invests in entrepreneurial companies that are developing pharmaceutical assets.
Business Model:
Revenue: $24M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Care Capital Information
Geographic Data
Address: PO Box 276
City: Avon-by-the-Sea
State: NJ
Zip: 07717
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Care Capital is a life sciences–focused venture capital firm that invests in entrepreneurial companies which are engaged in the development of pharmaceutical assets. The company provides its services to both private and public opportunities in the United States and Europe. It manages approximately $500 million in capital. Care Capital was established in 2000 and is based in Princeton, New Jersey.
Contact Phone:
+16096838300
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2006 | MPV | Venture Round | 14M |
| 8/2002 | Archemix | Series A | 51.8M |
| 4/2002 | Dynavax Technologies | Series D | 0 |
| 4/2004 | Archemix | Series B | 50M |
| 6/2003 | Orqis Medical | Series C | 25M |
| 4/2004 | Inotek Pharmaceuticals | Series A | 20M |
| 4/2004 | Cardiokine | Series A | 37M |
| 1/2009 | Anacor Pharmaceutical | Series E | 0 |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 6/2001 | Orqis Medical | Series B | 5.2M |
| 1/2012 | Elevation Pharmaceuticals | Series B | 0 |
| 9/2011 | Elevation Pharmaceuticals | Series A | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
| 11/2005 | Inotek Pharmaceuticals | Series B | 35M |
| 8/2007 | Inotek Pharmaceuticals | Series C | 19.3M |
| 9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
| 7/2003 | Tercica | Series B | 44M |
| 1/2010 | MicroCHIPS | Venture Round | 16.5M |
| 7/2011 | Inotek Pharmaceuticals | Series D | 0 |
| 9/2013 | Inotek Pharmaceuticals | Venture Round | 0 |
| 3/2007 | Orqis Medical | Series D | 12M |
| 10/2001 | D Pharm LTD. | Series D | 0 |
| 12/2002 | Renovo | Series B | 33M |
| 3/2010 | Vaxart | Series B | 9M |
| 5/2006 | Cardiokine | Series B | 50M |
| 7/2007 | NephroGenex | Series A | 0 |
| 1/2010 | Elevation Pharmaceuticals | Series A | 30M |
| 5/2011 | BioCritica | Private Equity Round | 25M |
| 8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
| 6/2001 | NitroMed | Series E | 0 |
| 7/2008 | CoLucid Pharmaceuticals | Series B | 0 |
| 1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
| 5/2010 | NormOxys | Series B | 17.5M |
| 5/2005 | Anacor Pharmaceutical | Series C | 25M |
| 1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
| 9/2013 | Inotek Pharmaceuticals | Venture Round | 0 |
| 9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
| 7/2012 | Agile Therapeutics | Series C | 0 |
| 1/2012 | Elevation Pharmaceuticals | Series B | 0 |
| 9/2011 | Elevation Pharmaceuticals | Series A | 0 |
| 8/2011 | CoLucid Pharmaceuticals | Venture Round | 0 |
| 7/2011 | Inotek Pharmaceuticals | Series D | 0 |
| 5/2011 | BioCritica | Private Equity Round | 0 |
| 6/2010 | Agile Therapeutics | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
